Articles

Antibody Drug Conjugates: Innovation in Design, Development and Manufacture

Antibody Drug Conjugates: Innovation in Design, Development and Manufacture Wednesday 26 th  June, 2013 Barry Cross Conference Centre, Cambridge   The HealthTech...

Almac Successfully Completes Knowledge Transfer Partnership with Queens University

Almac   is pleased to announce the successful completion of the Knowledge Transfer Partnership (KTP) with Queens University Belfast, to develop, improve and embed bioprocesses in order...

EPSRC TOWN MEETING INVITATION - Challenges in characterising biopharmaceuticals for ease of manufacture

On behalf of EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies EPSRC TOWN MEETING INVITATION - Challenges in characterising biopharmaceuticals for ease of...

EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies - New Website to Promote Manufacturing Innovation

The EPSRC Centre opened in November 2011 and is a National Centre focused on delivering innovation in manufacturing research to assess emergent challenges facing the UK biopharmaceutical sector,...

Oligonucleotides - Challenges and Considerations for Industrialisation

EVENT announcement: In partnership with GSK and GE Healthcare Life Sciences, the HealthTech and Medicines KTN is organising a meeting focusing on the challenges and considerations for...

Accelerating Novel Therapies - Annual bioProcessUK Conference launched

9 th Annual bioProcessUK Conference, 28 th -29 th November 2012, Bristol       Click here for conference website   Registration now...

Industry welcomes new £500m biopharmaceuticals manufacturing investment

GlakoSmithKline have announced that the company is to invest £500 million in manufacturing facilities in the UK , including £350 million in building a new biopharmaceutical...

NEW: Funding Announcements for the Life Sciences

The TSB recently announced its latest activity for its Stratified Medicines Stratified Medicine funding call under SBRI – Diagnostics for Adverse or Non-Response. The government is...

Meeting Report for the 2nd Meeting of the Biopharmaceutical Analytical Group

Please click here to read the meeting report of the Biopharmaceutical Analytical Group that was kindly hosted by Lonza at their site in SLough on 21 February 2012.

Date announced for 9th Annual bioProcessUK Conference - Accelerating Novel Therapies

9th Annual bioProcessUK Conference - Accelerating Novel Therapies   28th – 29th November 2012 The Grand Hotel, Bristol   We are delighted to announce...

New - TSB Funding calls

The HealthTech and Medicines KTN would like to draw your attention to two funding calls with relevance for our sector.   1. Technology Inspired Innovation This call is open...

Registration closed Using Peptides to support Therapeutic Intervention Meeting

Due to high demand, registration is now closed   The is the first HealthTech and Medicines KTN meeting on this focus, and is kindly being sponsored by PolyTherics. The interest...

8th Annual bioProcessUK Conference - One month to go! Full Programme,Workshops and Masterclasses

Don’t miss out on your chance to attend the 8th Annual bioProcessUK Conference at the Science Centre, Glasgow   This year’s conference is now only 1 month away...

8th Annual bioProcessUK Conference Launched! Registration now Open!

The Annual bioProcessUK Conference has now launched and registration is open.   Please visite the official conference website for further information: ...

8th Annual bioProcessUK Conference 2011 - Venue Confirmed!

The HealthTech and Medicines KTN is delighted to announce the launch of the 8th Annual bioProcessUK Conference 2011.This years’ two day event will take place on Wednesday 30 th November ...

Osaka University, Japan seeking European companies interested in accepting internships.

Osaka University, the 3rd-ranked university in Japan, is now running 'CLIC PhD internship program' and seeks European companies which are interested in accepting internships. This program is...

Report published on Assessment of the UK Biopharmaceutical Portfolio Value

As part of bioProcessUK’s annual activity on sector information, Unicorn Biologics undertook an assessment of the UK biopharmaceutical portfolio on behalf of the KTN. This report is now...

8th Annual Global Biopharmaceutical Manufacturing Study Global Industry Survey Invitation

bioProcessUK, part of the HealthTech and Medicines KTN is pleased to support this annual survey conducted by BioPlan Associates Inc, as in previous years. Please do ‘ Make sure your...

UK Government Growth review and consultation on Patent Box and R+D tax credits launched

The Government’s growth review “The path to strong, sustainable and balanced growth", was recently launched by the Chancellor of the Exchequer, with a road map to provide...
Showing 1 - 20 of 26 results.
Items per Page 20
of 2

Most read articles

Report published on Assessment of the UK Biopharmaceutical Portfolio Value

As part of bioProcessUK’s annual activity on sector information, Unicorn Biologics...

TSB funding call Technology-Inspired Collaborative R+D High Value Manufacturing

The HealthTech and Medicines KTN wanted you to be aware of the latest announcement from the ...

8th Annual bioProcessUK Conference 2011 - Venue Confirmed!

The HealthTech and Medicines KTN is delighted to announce the launch of the 8th Annual...